DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/x9s576/cancer_treatment) has announced the addition of the "Cancer Treatment Drugs Markets in China" report to their offering.
China's demand for Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. Major producers in China are profiled.
Key Topics Covered:
II. BUSINESS ENVIRONMENT
III. CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
IV. CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
V. CANCER TREATMENT DRUGS MARKET OUTLOOKS
VI. MARKETING STRATEGIES
VII. CANCER TREATMENT DRUGS PROFILES AND DIRECTORY
- Shenzhen Wanle Pharmaceutical Co.,Ltd
- Beijing SL Pharmaceutical Co.,Ltd
For more information visit http://www.researchandmarkets.com/research/x9s576/cancer_treatment